Observational cross-sectional study to evaluate the effects of self-medication with topical agents used by patients for superficial fungal skin infection at tertiary care hospital in Mumbai
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20201761Keywords:
Fixed dose combinations, Irritant, Steroids, Self-medication, Superficial fungal infectionAbstract
Background: Superficial fungal infections of the hair, skin, and nails are a major cause of morbidity in the world and their incidence continues to increase. While self-medication is also one of the major health concerns for health authorities worldwide. The aim of the study was to evaluate the effects of topical agents used by patients for self-medication, to enlisting the topical agents used by patients for self-medication, to ensure by whose suggestion’s patients engaged in self-medication.
Methods: It was an observational cross-sectional study which was conducted at the outpatient department (OPD) of dermatology in tertiary care hospital. A detailed history of the participant was recorded regarding topical agents used for self-medication and their effects were documented in a predesigned case record form.
Results: The population consisted of 128 males and 87 females. All these 215 participants had used 61 topical agents of different brand names and the majority of were irritant, corticosteroids and antifungal much high in use. Among 215 participants, 111 had temporary relief from the infection and reoccurred after stopping its use. 98 showed aggravation in their infection among which 90 showed effects like irritation, burning and itching at the application site, while 8 participants showed dryness or flaking of skin.
Conclusions: Self-medication is widely practiced among patients with a superficial fungal skin infection in Mumbai. A pharmacist was the major source for obtaining these topical agents. We can conclude, there is a need to counsel and discourage patients from self-medication and regulations for dispensing the prescribed drugs should be made stringent.
References
Hoog DS, Monod M, Dawson T, Boekhout T, Mayser P, Graser Y. Skin Fungi from Colonization to Infection. Microbiology Spectrum. 2017;5(4):1-17.
Sajith M, Lokhande K, Padma S, Pawar A. Prevalance of various skin disorders and prescribing pattern of antihistamines in tertiary care hospital, Pune. Int J Pharma Sci Res (IJPSR). 2014;5(3):73-77.
Joel JJ, Jose N, Shastry CS. Patterns of skin disease and prescribing trends in rural India. Sch Acad J Pharm. 2013;2(4):304-9.
Das K. Pattern of dermatological diseases in Gauhati medical college and hospital Guwahati. Indian J of Dermatology. 2003;69(1):16-18.
Piro DJ. Pharmacotherapy. New York: McGraw Hill. 1st edition: 2008: 1741-1785.
Grover S, Ranyal R, Bedi M. A cross section of skin diseases in rural Allahabad. Indian J Dermatology. 2008;53(4):179-81.
Yuwnate A, Chandane R, Giri K, Yunati M, Sirsam S. A multicentre pharmacoepidemiological study of dermatological disorders in Wardha district. Int J Basic Clinical Pharmacology. 2013;2(6):751-56.
Sclafer J, Slamet L, Visscher DG. Appropriateness of self-medication: method development and testing in urban Indonesia. J Clinical Pharmacy Therapeutics. 1997;22(4):261-72.
Phalke V, Phalke D, Durgawale P. Self-medication practices in rural Maharashtra. Indian J Community Medicine. 2006;31(1):34-5.
Sharma R, Verma U, Sharma C, Kapoor B. Self-medication among urban population of Jammu city. Indian J Pharmacology. 2005;37(1):40-3.
Shakoor O, Taylor RB, Behrens RH. Assessment of the incidence of substandard drugs in developing countries. Tropical Medicine Int Health. 1997;2(9):839-45.
Elghblawi E. Extensive ‘Tinea Incognito’ Due to Topical Steroid: A Case Report. JMED Res. 2013;2013(2013):1-3.
Deb P, Mohanty I, Slathia I, Verma V. Drug utilisation and self-medication pattern of anti-fungal drugs in dermatology outpatient department of a tertiary care hospital. Int J Basic Clinical Pharmacology. 2017;6(9):2189-92.
Dabas R, Janney MS, Subramaniyan R, Arora S, Lal VS, Donaparthi N. Use of over-the-counter topical medications in dermatophytosis: A cross-sectional, single-center, pilot study from a tertiary care hospital. Indian J Drugs in Dermatology. 2018;4(1):13-17.
Dutta B, Rasul ES, Boro B. Clinico‑epidemiological study of tinea incognito with microbiological correlation. Indian J Dermatol Venereol Leprol. 2017;83(3):326‑31.
Mahar S, Mahajan K, Agarwal S, Kar HK, Bhattacharya SK. Topical corticosteroid misuse: The scenario in patients attending a tertiary care hospital in New Delhi. J Clinical Diagnostic Res. 2016;10(12):16‑20.
Sheth HJ, Rathod SP, Chaudhary RG, Malhotra SD, Patel PR. Tineaincognito with unjustified use of potent topical corticosteroids: A case series. Int J of Basic and Clinical Pharmacology. 2017;6(8):2087-90.
Kim WJ, Kim TW, Mun JH, Song M, Kim HS, Ko H C, et al. Tinea incognito in Korea and its risk factors: Nine‑year multicenter survey. J Korean Med Sci. 2013;28(1):145‑51.
Ansar A, Farshchian M, Nazeri H, Ghiasian SA. Clinico‑epidemiological and mycological aspects of tinea incognito in Iran: A 16 years study. Med Mycol J. 2011;52(1):25‑32.
Dogra S, Uprety S. The menace of chronic and recurrent dermatophytosis in India: Is the problem deeper than we perceive. Indian Dermatol Online J. 2016;7(2):73‑6.
Narang T, Mahajan R, Dogra S. Dermatophytosis: Fighting the challenge: Conference proceedings and learning points. September 2‑3, 2017, PGIMER, Chandigarh, India. Indian Dermatol Online J. 2017;8(6):527‑33.
Kumar S, Goyal A, Gupta YK. Abuse of topical corticosteroids in India: Concerns and the way forward. J Pharmacol Pharmacother. 2016;7(1):1‑5.
